期刊文献+

拜新同联合依那普利治疗老年顽固性高血压疗效观察 被引量:2

Curative Effect Observation of Adalat Combined with Enalapril in Treating Senile Patients with Intractable Hypertension
下载PDF
导出
摘要 目的观察拜新同联合依那普利治疗老年顽固性高血压的临床疗效。方法60例老年顽固性高血压患者给予拜新同30~60mg 1次/d,依那普利5~10mg 2次/d,治疗8周后采取自身对照比较治疗前后血压指标,评估其临床疗效。结果服药4周,总有效率76.67%,服药8周,总有效率91.67%。结论拜新同联合依那普利治疗老年顽固性高血压疗效较好。 Objective To observe the clinical curative effect of adalat combined with enalapril in treating senile patients with intractable hypertension. Methods 30 - 60 mg of adalat, once a day, and 5 - 10 mg of enalapril, twice a day were administrated to 60 senile cases with intractable hypertension ; self contrast comparison of the blood pressure before and after treatment was made 8 weeks after treatment. Results The total effective rate was 76. 67% 4 weeks after treatment and 91.67% 8 weeks after treatment. Conclusions Adalat combined with enalapril is of good curative effect in treating senile patients with intractable hypertension.
出处 《西南军医》 2009年第3期402-403,共2页 Journal of Military Surgeon in Southwest China
关键词 拜新同 依那普利 顽固性高血压 adalat enalapril intractable hypertension
  • 相关文献

参考文献1

二级参考文献32

  • 1中国高血压防治指南修订委员会.中国高血压防治指南(2005年修订版).高血压杂志,2005,134:2-2.
  • 2Calhoun DA, Jones D,Textor S, et al. Resistant hypertension : diagnosis, evaluation, and treatment[ J]. Hypertension,2008,51 : 1403-1414.
  • 3Chobanian AV,Bakris GL. The Seventh Report of the Joint National Committee on the Detection,Evaluation, and Treatment of High Blood Pressure:the JNC 7 report [ J ]. JAMA,2003,289:2560-2572.
  • 4Peralta CA,Hicks LS,Chertow GM,et al. Control of hypertension in adults with chronic kidney disease in the United States [ J]. Hypertension, 2005,45:1119- 1124.
  • 5Setaeo JF, Black HR. Refractory- hypertension [ J ]. N Engl J Med, 1992,327 : 543-547.
  • 6The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic : the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) [ J ]. JAMA ,2002,288:2981-2997.
  • 7Cushman WC,Ford CE, Cutler JA,et al. Success and predictors of blood pressure control in diverse North American settings:the Antihypertensive and Lipid- Lowering and Treatment to Prevent Heart Attack Trial (ALLHAT) [ J ]. J Clin Hypertens ,2002,4:393-404.
  • 8Black HR,Elliott WJ,Grandite G,et al. Principal result of controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) Trial [ J ]. JAMA, 2003,289 : 2073 -2082.
  • 9Julius S, Kjeldsen SE, Brunner H, et al. VALUE trial: long-term blood pressure trends in 13449 patients with hypertension and high cardiovascular risk[ J]. Am J Hypertens ,2003,16:544-548.
  • 10Messerli FH,Ventura HO, Amodeo C. Osler's maneuver and pseudo hypertension[ J]. N Engl J Med, 1985,312 : 1548-1551.

共引文献6

同被引文献21

  • 1张维忠.顽固性高血压的评估与处理[J].内科急危重症杂志,2004,10(2):60-61. 被引量:17
  • 2陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2010:282.
  • 3Lavie p, Hoffstein V. Sleep apnea syndrome: a possible contributing factor to resistant hypertension[J]. Sleep, 2001,24: 721-725.
  • 4Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diag- nosis, evaluation, and treatment[J]. Hypertension, 2008,51:1403- 1414.
  • 5Yakovlevitch M, Black HR. Resistant hypcrtension in a tertiary care clinic[J]. Arch Intern Med, 1991,15(6):1786-1792.
  • 6Zannad F. Aldosterone mxtagonist in resistant hypertension[J]. J Hy pertens, 2007,25(4) :747-750.
  • 7Moser M, Setaro JF. Resistant or difficult control hypertension[J]. N Engl J reed, 2006,355 : 385 - 392.
  • 8Daniel A. AIdosterone and the vasculature: mechanisms mediating re- sistant hypertension[J]. J Clin Hypertens, 2007, 9(Suppl 1 ) : 13 - 18.
  • 9中国高血压防治指南修订委员会.中国高血压防治指南(2005年修订版).高血压杂志,2005,134:2-2.
  • 10张运,张梅.KAPLAN临床高血压[M].8版.济南:山东科学技术出版社,2004:15-16.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部